In his first state of the province address, the new Free State Premier Mxolisi Dukwana said the province will no longer be used as the breeding ground for corruption. Refilwe Mochoari asked him about this and the fate of the head of the provincial health department, who is charged with contravening the Public Finance Management Act.
Cystic fibrosis (CF) is a debilitating and often deadly disease. Until recently, the only treatments for its symptoms were difficult to administer and time-consuming. Life-changing new treatments that dramatically improve the prognosis for people with the disease have been developed, but they are expensive and Vertex, the US company making the drugs, has decided against registering the drugs in South Africa. Cheri Nel, a woman living with CF, is now taking Vertex on in a South African court. Catherine Tomlinson unpacks the details.
For businesses and households that can afford it, solar panels and batteries offer a way to keep the lights on during South Africa’s ongoing bouts of loadshedding. Such technologies may also offer a solution for healthcare facilities, where a reliable energy supply can be a matter of life and death. Nthusang Lefafa spoke to stakeholders and experts in the public and private health sectors about the promise of solar energy to mitigate the impact of loadshedding on health services.
Investment in public health facilities is crucial as the country weathers storms on various fronts – from drought (water shortages) and flooding putting strain on health infrastructure to a harsh economic climate that makes private healthcare unaffordable to more and more people. Mbali Baduza and Matshidiso Lencoasa assess the investments in infrastructure in the budget and what it means for the planned National Health Insurance system.
Spending on public sector infrastructure over the 2023 medium-term expenditure framework (MTEF) is estimated at R903 billion and the health sector accounts for 5% of this. The well-documented poor maintenance and oversight of projects, also in the health sector, will require close monitoring of trends across the public sector, particularly where procurement and contracting is concerned, writes Zukiswa Kota.
The current treatment for drug-susceptible tuberculosis (TB) used in South Africa last for six months, effectively cures TB and is dirt cheap. Two studies in recent years have shown that TB can be cured in four or in some cases even two months, but price and other complications make these treatments tricky to implement. At a conference in Seattle last week, a major trial of an alternative four-month treatment reported disappointing findings. Elri Voigt unpacks the latest findings and asks what the prospects now are for shortening TB treatment.
Budgets, while important, are not the right mechanism to drive the structural change needed to improve the responsiveness of our public health system in meeting the needs of the population. But, argues Russel Rensburg, we can reorient the health system towards meeting the health needs of the population and then let the budget bolster the reforms. Here he provides some suggestions on how to go about it and contrasts that with the budget announced by Minister of Finance Enoch Godongwana this week.
Despite some improvement, the community-led monitoring group Ritshidze’s second report on key populations highlights that sex workers, people who use drugs and LGBTQIA+ community members are often still discriminated against when trying to access public health facilities. This can lead to treatment interruptions and some stopping their clinic visits. Nthusang Lefafa reports.
The Health Department’s recent response to submissions and its own recommendations on amendments to the National Health Insurance Bill sadly does not realise the gravity of the threat to the future of medicine selection and access. As the Bill currently stands, it will leave us at the mercy of advisory committees that bear no duty to be transparent in deciding which medicines people will be able to access under NHI, the authors argue.
Lenalidomide is an important medicine used for the treatment of multiple myeloma – a type of bone marrow cancer that is not curable and typically requires long-term, ongoing treatment. Over the last decade, the price of this drug has fluctuated dramatically in South Africa and patients and their doctors have gone to extreme lengths to access it. Catherine Tomlinson unpacks the remarkable recent history of lenalidomide.
In October last year, Eastern Cape Health MEC Nomakhosazana Meth announced a three-phase plan to address key challenges with the province’s emergency medical services. Siyabonga Kamnqa visited All Saints Hospital in Ngcobo – one of the 28 priority hospitals targeted in the plan to see what progress has been made.
It is a race against the clock to keep to the timetable for repairs at Charlotte Maxeke Johannesburg Academic Hospital. This as Gauteng’s public healthcare needs mount and the challenges of alleged criminal activity and inefficiencies at the hospital persist. Ufrieda Ho reports.